Stock research
VCYT Veracyte, Inc.
Healthcare • Medical - Diagnostics & Research
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers...…
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
1Y change
+149.40%
Range high
$60.49
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in VCYT?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $55.71
- Day High
- $59.92
- Day Low
- $54.73
- 52w High
- $60.91
- 52w Low
- $22.92
- Volume
- 1,482,438
- Avg Volume
- Beta
- 1.934
* TTM/most recent where available
Company
- Ticker
- VCYT
- Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
- CEO
- Marc Stapley
- Employees
- 755
- Website
- www.veracyte.com
Key Metrics
- Market Cap
- 4.77B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).